These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6461777)

  • 1. [Serum and urinary level of sodium piperacillin in patients with liver disease (author's transl)].
    Kakiuchi S; Tagawa S; Watanabe K; Kosaka Y; Takezawa H
    Jpn J Antibiot; 1982 Jan; 35(1):212-21. PubMed ID: 6461777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chemotherapy of biliary tract infections. XIV. Biliary excretion and gallbladder tissue levels of piperacillin (author's transl)].
    Tanimura H; Saito T; Sekiya T; Kobayashi N; Hikasa Y
    Jpn J Antibiot; 1981 Oct; 34(10):1401-9. PubMed ID: 6460883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetic studies of piperacillin after 4 g or 8 g intravenous injection in human healthy volunteers].
    Nakagawa K; Yasuda T; Nakajima Y; Watanabe Y; Noguchi M; Suzuki T
    Jpn J Antibiot; 1982 Dec; 35(12):2797-804. PubMed ID: 6222208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigation of the Efficacy of an Administration Plan for Tazobactam/Piperacillin (TAZ/PIPC) and the Incidence of Kidney and Hepatic Disorders].
    Senba M; Isami K; Yamashita K; Tsumagari K; Yamashina T; Sasaki E; Tsuruta M; Miyoshi T; Kawamata Y; Kozono A
    Yakugaku Zasshi; 2017; 137(10):1277-1284. PubMed ID: 28966268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fundamental studies of transferred concentration of piperacillin into maternal serum, umbilical cord serum and amniotic fluid].
    Iwasaki T; Machihara M
    Jpn J Antibiot; 1982 Sep; 35(9):2206-12. PubMed ID: 6216354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The formation of desethyl-piperacillin from piperacillin by human liver S9 in vitro.
    Komuro M; Maeda T; Hayakawa H; Allen KL; Green CE
    Biopharm Drug Dispos; 1997 Apr; 18(3):185-90. PubMed ID: 9113341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fundamental and clinical studies of piperacillin in the field of obstetrics and gynecology].
    Hiraike H; Haruta T; Takashima H; Kobayashi Y
    Jpn J Antibiot; 1982 Oct; 35(10):2364-70. PubMed ID: 6223155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical investigation of silymarin in chronic liver diseases (author's transl)].
    Realini S; Gonvers JJ; Hofstetter JR
    Schweiz Rundsch Med Prax; 1975 May; 64(19):595-8. PubMed ID: 51497
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fundamental and clinical studies of piperacillin in the field of obstetrics and gynecology].
    Ohtsuka T; Uemura T; Minaguchi H
    Jpn J Antibiot; 1982 Sep; 35(9):2200-5. PubMed ID: 6216353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fundamental and clinical studies on piperacillin in the field of obstetrics and gynecology].
    Yasuda J; Yamamoto T; Honjo H; Okada H; Kanao M; Yamamoto H
    Jpn J Antibiot; 1982 Oct; 35(10):2337-42. PubMed ID: 6223151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fundamental and clinical studies on piperacillin in the field of obstetrics and gynecology].
    Nakamura H; Iwata Y; Hayashi S
    Jpn J Antibiot; 1982 Sep; 35(9):2195-9. PubMed ID: 6216352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Half-life of rifampicin after repeated administration of different doses in humans.
    Curci G; Bergamini N; Delli Veneri F; Ninni A; Nitti V
    Chemotherapy; 1972; 17(6):373-81. PubMed ID: 5082603
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes in serum transaminases in liver diseases].
    Sessa R
    Rass Int Clin Ter; 1968 Mar; 48(6):347-57. PubMed ID: 5736033
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacokinetic study of piperacillin in the field of obstetrics and gynecology].
    Kusuhara K; Nakajima T; Yasuda M; Kuji N; Terajima Y; Hachiya S
    Jpn J Antibiot; 1982 Sep; 35(9):2189-94. PubMed ID: 6216351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of piperacillin dose on elimination kinetics in renal impairment.
    Aronoff GR; Sloan RS; Brier ME; Luft FC
    Eur J Clin Pharmacol; 1983; 24(4):543-7. PubMed ID: 6222908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The serum gamma-glutamyltranspeptidase level in clinical diagnosis (author's transl)].
    Mayr K
    Wien Klin Wochenschr; 1973 Feb; 85(6):83-7. PubMed ID: 4155171
    [No Abstract]   [Full Text] [Related]  

  • 17. [Piperacillin: pharmacokinetic studies on the biliary and renal excretion (author's transl)].
    Baier R; Puppel H; Zelder O; Zehner R
    Arzneimittelforschung; 1981; 31(5):857-61. PubMed ID: 6456008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypercoagulopathy with piperacillin administration in osteomyelitis.
    Miyazaki H; Yanagitani S; Matsumoto T; Yoshida K; Amoh Y; Watanabe T; Kubota Y; Inoue K
    Intern Med; 2000 May; 39(5):424-7. PubMed ID: 10830188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of crude drugs on experimental liver damages. II. Effect of new sesquiterpenoid "Furnaogermenone" (author's transl)].
    Yamahara J; Matsuda H; Sawada T; Sakurai H; Matsumura A; Toyama S; Suzuki I
    Yakugaku Zasshi; 1982 Mar; 102(3):272-77. PubMed ID: 7108757
    [No Abstract]   [Full Text] [Related]  

  • 20. [The SGLDH determination with the Jung's method in differential diagnosis of hepatobiliary diseases (author's transl)].
    Galanti B; Russo M; Nardiello S
    Quad Sclavo Diagn; 1977 Jun; 13(2):214-23. PubMed ID: 594307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.